DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Aschner P, Kipnes MS, Lunceford JK et al.
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.
Diabetes Care 2006;
29 (12) 2632-2637
http://www.ncbi.nlm.nih.gov/pubmed/17130196
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.